Doctor Speaks Out on Trasylol Recall

Apparently, the news for Bayer is getting worse on the Trasylol front. A medical researcher has condemned the drug company for it’s lack of cooperation in getting the dangerous drug used in thousands of heart surgeries off the market after his initial findings.

From Reuters:

Dr. Dennis Mangano, the study’s researcher, said during the program that 22,000 lives could have been saved if Trasylol had been taken off the market when he first published his study in January 2006, according to a CBS News report on its Web site ahead of a broadcast slated for next Sunday.

He said in the broadcast that Bayer failed to disclose to the FDA during an FDA advisory panel meeting in September 2006 — at which Mangano’s negative findings were discussed — that the German drugmaker had conducted its own research which confirmed the same dangers established by his study.

The chairman of the FDA advisory panel, Dr. William Hiatt, told 60 Minutes he would have voted to remove Trasylol from the market had he been informed about Bayer’s study, according to the CBS report.

Bayer spokeswoman Meredith Fischer said she could not comment about the broadcast until it is aired, including allegations that the drugmaker had failed to protect patients.

She said Bayer is facing a number of product-liability lawsuits filed by patients who had taken the medicine or their families, but said she not know how many lawsuits were filed.

There are certainly many patients and families that have been affected by this. I’m willing to talk with anyone who has questions regarding Trasylol or other dangerous drugs. If you have any questions please contact me at your convenience.